Search

Ali Z Fadhel

Examiner (ID: 9147, Phone: (571)270-0267 , Office: P/1772 )

Most Active Art Unit
1772
Art Unit(s)
1772
Total Applications
589
Issued Applications
422
Pending Applications
57
Abandoned Applications
110

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 18221775 [patent_doc_number] => 20230060769 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-03-02 [patent_title] => COMPOSITION AND METHOD HAVING ENHANCED LSESr TO MAINTAIN AND PROMOTE URINARY AND PROSTATE FUNCTION IN A HUMAN [patent_app_type] => utility [patent_app_number] => 17/818011 [patent_app_country] => US [patent_app_date] => 2022-08-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18862 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -20 [patent_words_short_claim] => 81 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17818011 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/818011
COMPOSITION AND METHOD HAVING ENHANCED LSESr TO MAINTAIN AND PROMOTE URINARY AND PROSTATE FUNCTION IN A HUMAN Aug 7, 2022 Pending
Array ( [id] => 18018856 [patent_doc_number] => 20220370355 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-11-24 [patent_title] => Lapatinib particles and uses thereof [patent_app_type] => utility [patent_app_number] => 17/812479 [patent_app_country] => US [patent_app_date] => 2022-07-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7782 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -24 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17812479 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/812479
Lapatinib particles and uses thereof Jul 13, 2022 Issued
Array ( [id] => 17836222 [patent_doc_number] => 20220273527 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-09-01 [patent_title] => Pouches Comprising Oral Care Active Agents [patent_app_type] => utility [patent_app_number] => 17/745923 [patent_app_country] => US [patent_app_date] => 2022-05-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 30213 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17745923 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/745923
Pouches Comprising Oral Care Active Agents May 16, 2022 Pending
Array ( [id] => 18603362 [patent_doc_number] => 11744802 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-09-05 [patent_title] => Therapeutic compositions for treatment of human immunodeficiency virus [patent_app_type] => utility [patent_app_number] => 17/738803 [patent_app_country] => US [patent_app_date] => 2022-05-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 29562 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17738803 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/738803
Therapeutic compositions for treatment of human immunodeficiency virus May 5, 2022 Issued
Array ( [id] => 18250955 [patent_doc_number] => 20230077994 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-03-16 [patent_title] => ELECTRONIC VAPOR LIQUID COMPOSITION AND METHOD OF USE IN A DISPENSER [patent_app_type] => utility [patent_app_number] => 17/719912 [patent_app_country] => US [patent_app_date] => 2022-04-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7338 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17719912 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/719912
ELECTRONIC VAPOR LIQUID COMPOSITION AND METHOD OF USE IN A DISPENSER Apr 12, 2022 Pending
Array ( [id] => 18018824 [patent_doc_number] => 20220370323 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-11-24 [patent_title] => CROSS LINKED SILK-HYALURONIC ACID COMPOSITION [patent_app_type] => utility [patent_app_number] => 17/713069 [patent_app_country] => US [patent_app_date] => 2022-04-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15929 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17713069 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/713069
CROSS LINKED SILK-HYALURONIC ACID COMPOSITION Apr 3, 2022 Abandoned
Array ( [id] => 19338145 [patent_doc_number] => 12048313 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-07-30 [patent_title] => Combination of 25-hydroxyvitamin D and antioxidants/anti-inflammatories for poultry ovarian health [patent_app_type] => utility [patent_app_number] => 17/703955 [patent_app_country] => US [patent_app_date] => 2022-03-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 4085 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 128 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17703955 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/703955
Combination of 25-hydroxyvitamin D and antioxidants/anti-inflammatories for poultry ovarian health Mar 23, 2022 Issued
Array ( [id] => 17881064 [patent_doc_number] => 20220296541 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-09-22 [patent_title] => N-PALMITOYL-ETHANOLAMIDE FOR USE IN THE PREVENTION OF COLORECTAL CARCINOMA [patent_app_type] => utility [patent_app_number] => 17/691572 [patent_app_country] => US [patent_app_date] => 2022-03-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3804 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17691572 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/691572
N-PALMITOYL-ETHANOLAMIDE FOR USE IN THE PREVENTION OF COLORECTAL CARCINOMA Mar 9, 2022 Pending
Array ( [id] => 17670820 [patent_doc_number] => 20220183987 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-06-16 [patent_title] => PHARMACEUTICAL COMPOSITIONS OF PIMOBENDAN [patent_app_type] => utility [patent_app_number] => 17/685830 [patent_app_country] => US [patent_app_date] => 2022-03-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5813 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17685830 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/685830
PHARMACEUTICAL COMPOSITIONS OF PIMOBENDAN Mar 2, 2022 Pending
Array ( [id] => 17828446 [patent_doc_number] => 20220265750 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-08-25 [patent_title] => COMPOSITION FOR TREATMENT OF TOPICAL DERMATOLOGICAL BACTERIAL SKIN CONDITIONS [patent_app_type] => utility [patent_app_number] => 17/680970 [patent_app_country] => US [patent_app_date] => 2022-02-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 40793 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -20 [patent_words_short_claim] => 95 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17680970 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/680970
COMPOSITION FOR TREATMENT OF TOPICAL DERMATOLOGICAL BACTERIAL SKIN CONDITIONS Feb 24, 2022 Pending
Array ( [id] => 17561657 [patent_doc_number] => 20220125806 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-04-28 [patent_title] => STABILIZED MODIFIED RELEASE VITAMIN D FORMULATION AND METHOD OF ADMINISTERING SAME [patent_app_type] => utility [patent_app_number] => 17/570194 [patent_app_country] => US [patent_app_date] => 2022-01-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19213 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 155 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17570194 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/570194
STABILIZED MODIFIED RELEASE VITAMIN D FORMULATION AND METHOD OF ADMINISTERING SAME Jan 5, 2022 Pending
Array ( [id] => 17685714 [patent_doc_number] => 20220193006 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-06-23 [patent_title] => COMPOSITIONS FOR EFFECTIVE MANAGEMENT OF FIBROBLAST-LIKE SYNOVIOCYTES MEDIATED RHEUMATOID ARTHRITIS [patent_app_type] => utility [patent_app_number] => 17/552535 [patent_app_country] => US [patent_app_date] => 2021-12-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6480 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -25 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17552535 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/552535
COMPOSITIONS FOR EFFECTIVE MANAGEMENT OF FIBROBLAST-LIKE SYNOVIOCYTES MEDIATED RHEUMATOID ARTHRITIS Dec 15, 2021 Pending
Array ( [id] => 17702760 [patent_doc_number] => 20220202766 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-06-30 [patent_title] => CENTRAL NERVOUS SYSTEM HEALTH SUPPLEMENT [patent_app_type] => utility [patent_app_number] => 17/644069 [patent_app_country] => US [patent_app_date] => 2021-12-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12093 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17644069 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/644069
CENTRAL NERVOUS SYSTEM HEALTH SUPPLEMENT Dec 12, 2021 Pending
Array ( [id] => 17503290 [patent_doc_number] => 20220096392 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-03-31 [patent_title] => EDDS CHELATED NANOCERIA WITH CATALASE-LIKE ACTIVITY [patent_app_type] => utility [patent_app_number] => 17/546640 [patent_app_country] => US [patent_app_date] => 2021-12-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6755 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -7 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17546640 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/546640
Edds chelated nanoceria with catalase-like activity Dec 8, 2021 Issued
Array ( [id] => 17685708 [patent_doc_number] => 20220193000 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-06-23 [patent_title] => KETAMINE TRANSDERMAL DELIVERY SYSTEM [patent_app_type] => utility [patent_app_number] => 17/540695 [patent_app_country] => US [patent_app_date] => 2021-12-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9216 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17540695 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/540695
KETAMINE TRANSDERMAL DELIVERY SYSTEM Dec 1, 2021 Abandoned
Array ( [id] => 18503554 [patent_doc_number] => 11701344 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-07-18 [patent_title] => Bendamustine pharmaceutical compositions [patent_app_type] => utility [patent_app_number] => 17/532874 [patent_app_country] => US [patent_app_date] => 2021-11-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 15 [patent_no_of_words] => 16314 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 87 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17532874 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/532874
Bendamustine pharmaceutical compositions Nov 21, 2021 Issued
Array ( [id] => 18050619 [patent_doc_number] => 11523984 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2022-12-13 [patent_title] => Compositions and methods of administering baclofen [patent_app_type] => utility [patent_app_number] => 17/525298 [patent_app_country] => US [patent_app_date] => 2021-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9750 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 151 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17525298 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/525298
Compositions and methods of administering baclofen Nov 11, 2021 Issued
Array ( [id] => 19134591 [patent_doc_number] => 11969500 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-04-30 [patent_title] => Implantable depots for the controlled release of therapeutic agents [patent_app_type] => utility [patent_app_number] => 17/454320 [patent_app_country] => US [patent_app_date] => 2021-11-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 33 [patent_figures_cnt] => 58 [patent_no_of_words] => 44934 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 151 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17454320 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/454320
Implantable depots for the controlled release of therapeutic agents Nov 9, 2021 Issued
Array ( [id] => 17519266 [patent_doc_number] => 20220105114 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-04-07 [patent_title] => METHODS FOR TREATING CHEMORESISTANT CANCER-INITIATING CELLS [patent_app_type] => utility [patent_app_number] => 17/499648 [patent_app_country] => US [patent_app_date] => 2021-10-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11405 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17499648 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/499648
METHODS FOR TREATING CHEMORESISTANT CANCER-INITIATING CELLS Oct 11, 2021 Pending
Array ( [id] => 19180995 [patent_doc_number] => 11987576 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-05-21 [patent_title] => Compositions and methods for decreasing, or preventing or reversing gain of, skin pigmentation in a mammalian subject [patent_app_type] => utility [patent_app_number] => 17/480948 [patent_app_country] => US [patent_app_date] => 2021-09-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 40 [patent_no_of_words] => 13710 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 167 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17480948 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/480948
Compositions and methods for decreasing, or preventing or reversing gain of, skin pigmentation in a mammalian subject Sep 20, 2021 Issued
Menu